Anti-hemorrhoidal potential of Microspheres containing Dolichandrone falcata leaf extract
DOI:
https://doi.org/10.47552/ijam.v17i2.7194Keywords:
In-silico, Anti-hemorrhoidal, Flavonoids, Microspheres, Zeta potential, In-vivoAbstract
Hemorrhoids affect a significant portion of the global population, generating a constant need for safe and efficient treatments. Plant-based remedies offer promising alternatives, but their therapeutic efficiency can often be compromised by their poor oral bioavailability. This study investigates the development of a chitosan based sustained release microsphere formulation containing Dolichandrone falcata extract for the treatment of hemorrhoids. In-silico molecular docking studies were conducted on key flavonoids such as quercetin and rutin, against hemorrhoidal target proteins. The leaf extract of D. falcata was prepared using maceration technique and characterized for its phytochemical constituents, revealing a high total flavonoid content. Microspheres were formulated using the emulsion crosslinking method and evaluated for physical characteristics and in-vitro drug release. Finally, in-vivo anti-hemorrhoidal activity was assessed in a croton oil induced rat model. The docking results indicates strong binding affinities of quercetin and rutin to proteins such as MMP-9, NOS-2 and EGFR. The optimized microsphere formulation exhibited a high percentage yield (79.3%), good entrapment efficiency (73.3%), and a sustained in-vitro release profile (73.23% over 9 hrs). In-vivo studies demonstrated significant reduction in hemorrhoidal symptoms, comparable to standard treatment. The developed microspheres of D. falcata extract provide a promising, sustained-release herbal alternative for hemorrhoid management.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 International Journal of Ayurvedic Medicine

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.

